Physician profile
Christopher J Trosclair
NPI 1992236202
$2,822.78
in general payments reported to CMS, 2019-2025
18 companies · $525 in 2025
The $525 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $78.80 · 2021: $304 · 2022: $387 · 2023: $742 · 2024: $787 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,054.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,053.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,929.93 | 2022-2025 | Impella |
| Abbott Laboratories | $163.16 | 2022-2023 | 2nd Gen Centrimag Primary Console |
| Baxter Healthcare | $141.14 | 2021-2022 | |
| La Jolla Pharmaceutical Company | $134.79 | 2023 | Xacduro |
| Glaxosmithkline, LLC. | $77.77 | 2021 | |
| Insmed, INC. | $60.23 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $46.67 | 2020-2021 | |
| Grifols USA, LLC | $42.63 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $36.67 | 2020-2021 | |
| Gilead Sciences, INC. | $32.04 | 2021 | |
| Pfizer INC. | $29.99 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.55 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $23.46 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.23 | 2025 | |
| Melinta Therapeutics, LLC | $17.21 | 2025 | Orbactiv, Kimyrsa, Rezzayo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.74 | 2021 | |
| Boston Scientific Corporation | $15.29 | 2024 | |
| Genentech USA, INC. | $9.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Trosclair listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.